The Triple Marker Test is a vital prenatal screening performed during the second trimester of pregnancy, usually between the 15th and 20th weeks. It measures levels of three key substances in the mother’s blood—Alpha-fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), and Estriol. These markers help assess the risk of certain genetic disorders and birth defects in the fetus, such as Down syndrome, Trisomy 18, and neural tube defects. While not a diagnostic test, it helps expectant parents and healthcare providers determine if further testing is needed. The Triple Marker Test is safe, non-invasive, and provides valuable information to support a healthy pregnancy. Read More... https://redcliffelabs.com/triple-marker-test